Clinical Trials Directory

Trials / Completed

CompletedNCT06378801

Radicle Relaxation 24: A Study of Health and Wellness Products on Stress and Related Health Outcomes

Radicle Relaxation™ 24: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Stress and Related Health Outcomes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,700 (actual)
Sponsor
Radicle Science · Industry
Sex
All
Age
21 Years – 105 Years
Healthy volunteers
Accepted

Summary

A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on stress and related health outcomes

Detailed description

This is a randomized, double-blind, placebo-controlled study conducted with adult participants, residing in the United States. Eligible participants will (1) endorse a desire for less stress (2) have the opportunity for meaningful improvement (at least 20%) in their primary health outcome, and (3) express acceptance in taking a product and not knowing its formulation until the end of the study. Participants that report a known cardiac dysfunction, liver or kidney disease may be excluded. Participants that report a known contraindication or with well-established, significant safety concerns due to illness will be excluded. Heavy drinkers and those who report they are pregnant, trying to become pregnant, or breastfeeding will be excluded. Participants that report taking medications with a known contraindication or with well-established, significant safety concerns will be excluded. Self-reported data are collected electronically from eligible participants over 7 weeks. Participant reports of health indicators will be collected during baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlacebo Control Form 1Participants will use their Placebo Control Form 1 as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTRelaxation Active Study Product 1.1Participants will use their Radicle Relaxation Active Study Product 1.1 as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTPlacebo Control Form 2Participants will use their Placebo Control Form 2 as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTRelaxation Active Study Product 2.1Participants will use their Radicle Relaxation Active Study Product 2.1 as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTPlacebo Control Form 3Participants will use their Placebo Control Form 3 as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTRelaxation Active Study Product 3.1Participants will use their Radicle Relaxation Active Study Product 3.1 as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTPlacebo Control Form 4Participants will use their Placebo Control Form 4 as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTRelaxation Active Study Product 4.1Participants will use their Radicle Relaxation Active Study Product 4.1 as directed for a period of 6 weeks.
DIETARY_SUPPLEMENTRelaxation Active Study Product 4.2Participants will use their Radicle Relaxation Active Study Product 4.2 as directed for a period of 6 weeks.

Timeline

Start date
2024-02-29
Primary completion
2024-11-01
Completion
2024-11-01
First posted
2024-04-22
Last updated
2025-11-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06378801. Inclusion in this directory is not an endorsement.